Cover Image

Docking and Dynamics Study of Phytochemicals as Potent Inhibitors against SARS-CoV-2 Main Protease

Coronavirus Infectious Disease-19 (COVID-19) caused by coronavirus 2 is a global health hazard. The lack of medications against the disease is a major concern of the research community today. Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease (SARS-CoV-2 MPro) is the most extensively stud...

Full description

Saved in:

Bibliographic Details
Main Authors:	Palla Ramprasad (Author), Arunkumar Babu (Author), Suveena Sukumaran (Author)
Format:	Book
Published:	Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
by: Fucheng Song, et al.
Published: (2023)

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations
by: Mehdi Oubahmane, et al.
Published: (2023)

In silico phytochemicals analysis as inhibitors of the SARS-COV-2 main protease
by: Ekaterina Serikova, et al.
Published: (2022)

Chlorhexidine and SARS-CoV-2 main protease: Molecular docking study
by: Vishakha Grover, et al.
Published: (2022)

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
by: Xinbo Yang, et al.
Published: (2022)

Molecular Docking of Novel 5-O-benzoylpinostrobin Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Mohammad Rizki Fadhil Pratama, et al.
Published: (2020)

In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
by: Yogesh Kumar, et al.
Published: (2020)

Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study
by: Mahmoud A. A. Ibrahim, et al.
Published: (2022)

Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: In vitro, molecular docking and simulation analysis
by: Yousef T.M. Alharbi, et al.
Published: (2024)

Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study
by: Sumit Arora, et al.
Published: (2020)

Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2: In silico study
by: Nitish Kumar, et al.
Published: (2021)

Development of potent and effective SARS-CoV-2 main protease inhibitors based on maleimide analogs for the potential treatment of COVID-19
by: Karol Biernacki, et al.
Published: (2024)

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
by: Soumya Gulab Katre, et al.
Published: (2022)

Flavonoid compounds of buah merah (Pandanus conoideus Lamk) as a potent SARS-CoV-2 main protease inhibitor: in silico approach
by: Abd. Kakhar Umar
Published: (2021)

Molecular docking and dynamic simulations study for repurposing of multitarget coumarins against SARS-CoV-2 main protease, papain-like protease and RNA-dependent RNA polymerase
by: Mai E. Shoman, et al.
Published: (2022)

Molecular docking study and molecular dynamics simulation of spice metabolites against main protease enzymes and NSP3 macrodomain SARS CoV-2
by: Purwaniati Purwaniati, et al.
Published: (2022)

New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors
by: Antonella Messore, et al.
Published: (2024)

Prediction of Asiatic Acid Derivatives Affinity Against SARS-CoV-2 Main Protease Using Molecular Docking
by: Ida Musfiroh, et al.
Published: (2020)

Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
by: Chunlong Ma, et al.
Published: (2022)

Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
by: Matteo Pavan, et al.
Published: (2021)

Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
by: Hylemariam Mihiretie Mengist, et al.
Published: (2021)

Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
by: Jiawei Liu, et al.
Published: (2022)

In Silico Prediction of Novel Inhibitors of SARS-CoV-2 Main Protease through Structure-Based Virtual Screening and Molecular Dynamic Simulation
by: Sobia Ahsan Halim, et al.
Published: (2021)

Discovery of Novel and Highly Potent Inhibitors of SARS CoV-2 Papain-Like Protease Through Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, Molecular Dynamics Simulations, and Biological Evaluation
by: Xiaoyan Tian, et al.
Published: (2022)

Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential
by: Arafa Musa, et al.
Published: (2023)

Molecular Docking Study of Nigella sativa Alkaloid Compounds as the Inhibitor of Papain-Like Protease SARS-CoV-2
by: Gusnia Meilin Gholam, et al.
Published: (2023)

Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning
by: Karina Eurídice Juárez-Mercado, et al.
Published: (2024)

Molecular docking analysis of peptide-based antiviral agents against SARS-CoV-2 main protease: an approach towards drug repurposing
by: Abhishek Chaurasiya, et al.
Published: (2023)

Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease
by: Jawaria Jabeen, et al.
Published: (2024)

In silico investigation of HCV and RNA synthesis inhibitor antibiotic drugs as potential inhibitors of SARS‑CoV‑2 main protease (Mpro)
by: Merusomayajula V. Kishore, et al.
Published: (2024)

Jun12682, a potent SARS-CoV-2 papain-like protease inhibitor with exceptional antiviral efficacy in mice
by: Mianling Yang, et al.
Published: (2024)

Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
by: Mohamed Elagawany, et al.
Published: (2022)

Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study
by: Hu Wang, et al.
Published: (2022)

Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M<sup>pro</sup> Main Protease Inhibitors
by: Maria Nuria Peralta-Moreno, et al.
Published: (2023)

Phyllanthus tenellus Roxb. and Kaempferia parviflora Wall. ex Baker compounds as inhibitors of SARS-CoV-2 main protease and RNA-dependent RNA polymerase: A molecular docking study
by: Suhaina Supian, et al.
Published: (2022)

Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
by: Luca Pinzi, et al.
Published: (2021)

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020)

Identification of sulphonamide-tethered N-((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease
by: Mai H. ElNaggar, et al.
Published: (2023)

Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease
by: Bo Qin, et al.
Published: (2022)

Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2
by: Renhui Dai, et al.
Published: (2023)